… other therapeutics approved by the FDA, the number of cases due to the novel (COVID-19) …
-CoV-2 antigen presentation should aid our comprehension of COVID-19 pathogenesis.[ 5 ] …

… therapy and traditional Chinese medicine regimes. In examining leukocyte and cytokine activity
in COVID-19, we … severe infection, as well as current therapeutic strategies and possible …

… Moreover, we summarized the recent therapeutic strategies, which are either approved, …
role of DCs in COVID-19 immunopathogenesis can be hypothesized. In COVID-19, an increased …

… confirmed the positive infection for COVID-19 [31] and SARS-CoV-19 shares almost 80% …
In a nutshell, the pathogenesis of COVID-19 can be categorized as systemic disorders that …

… The pathogenesis of the new coronavirus is still not well defined. Most patients present with
… However, although the therapeutic strategy against the disease is of high importance the …

… pathogenesis and summarizes current knowledge about the potential mechanisms for off-label
agents widely used to treat COVID-19… this step might be a therapeutic approach [168]. …

… Clearly, therapeutic strategies are needed immediately to decrease viral spread, … mortality
and morbidities associated with COVID-19. Moreover, these strategies might reduce the tragic …

… immunopathology in Covid-19. Transcriptomic analysis of T-cells from the bronchoalveolar
lavage showed reduced IL-2 transcripts in severe cases compared to mild cases. Citation146 …

… Although the exact mechanism of pathogenesis in COVID-19 is … strategies to modulate
inflammatory responses [1]. Despite many efforts to improve therapeutic protocols for COVID-19, …

… Experimental data suggest that neutrophils may also be involved in the pathogenesis of
COVID-19, 34 as SARS-CoV-2 infection induces CXCL2 (GROβ) and CXCL8 (IL-8), two …